263 related articles for article (PubMed ID: 19416449)
1. Chronic ingestion of Porphyromonas gingivalis induces systemic nitric oxide response in mice.
Nemec A; Pavlica Z; Crossley DA; Sentjurc M; Jerin A; Erzen D; Vrecl M; Majdic G; Zdovc I; Petelin M; Skaleric U
Oral Microbiol Immunol; 2009 Jun; 24(3):204-10. PubMed ID: 19416449
[TBL] [Abstract][Full Text] [Related]
2. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice.
Nemec A; Pavlica Z; Petelin M; Crossley DA; Sentjurc M; Jerin A; Erzen D; Zdovc I; Hitti T; Skaleric U
Arch Oral Biol; 2010 Jul; 55(7):509-14. PubMed ID: 20430367
[TBL] [Abstract][Full Text] [Related]
3. Single gavage with Porphyromonas gingivalis reduces acute systemic nitric oxide response in mice.
Nemec A; Pavlica Z; Sentjurc M; Crossley DA; Jerin A; Erzen D; Zdovc I; Petelin M; Skaleric U
Oral Microbiol Immunol; 2008 Oct; 23(5):435-9. PubMed ID: 18793369
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.
Thomsen LL; Scott JM; Topley P; Knowles RG; Keerie AJ; Frend AJ
Cancer Res; 1997 Aug; 57(15):3300-4. PubMed ID: 9242464
[TBL] [Abstract][Full Text] [Related]
5. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide.
Katada K; Bihari A; Badhwar A; Yoshida N; Yoshikawa T; Potter RF; Cepinskas G
J Pharmacol Exp Ther; 2009 Jun; 329(3):919-27. PubMed ID: 19270191
[TBL] [Abstract][Full Text] [Related]
6. Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
Bachetti T; Pasini E; Suzuki H; Ferrari R
Crit Care Med; 2003 May; 31(5):1509-14. PubMed ID: 12771626
[TBL] [Abstract][Full Text] [Related]
7. Role of nitric oxide and nuclear factor-kappaB in the CYP2E1 potentiation of tumor necrosis factor alpha hepatotoxicity in mice.
Wu D; Xu C; Cederbaum A
Free Radic Biol Med; 2009 Feb; 46(4):480-91. PubMed ID: 19063961
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
Slomiany BL; Slomiany A
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):85-98. PubMed ID: 15082869
[TBL] [Abstract][Full Text] [Related]
9. Early systemic inflammatory response in mice after a single oral gavage with live Escherichia coli is evidenced by increased TNF-alpha and nitric oxide production.
Nemec A; Jerin A; Zdovc I; Budefeld T; Verstraete FJ; Eržen D; Sentjurc M; Petelin M; Hitti T; Pavlica Z
Res Vet Sci; 2012 Jun; 92(3):401-7. PubMed ID: 21489584
[TBL] [Abstract][Full Text] [Related]
10. Lipid A-associated proteins from Porphyromonas gingivalis stimulate release of nitric oxide by inducing expression of inducible nitric oxide synthase.
Choi EY; Hwang YM; Lee JY; Choi JI; Choi IS; Jin JY; Ko JS; Kim SJ
J Periodontal Res; 2007 Aug; 42(4):350-60. PubMed ID: 17559633
[TBL] [Abstract][Full Text] [Related]
11. [1400W blocks death pathway of LPS-induced activated-microglia to preOLs].
He YF; Chen HJ; Qian LH; Chen GY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):357-62. PubMed ID: 20497644
[TBL] [Abstract][Full Text] [Related]
12. Porphyromonas gingivalis stimulates the release of nitric oxide by inducing expression of inducible nitric oxide synthases and inhibiting endothelial nitric oxide synthases.
Sun W; Wu J; Lin L; Huang Y; Chen Q; Ji Y
J Periodontal Res; 2010 Jun; 45(3):381-8. PubMed ID: 20337893
[TBL] [Abstract][Full Text] [Related]
13. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1--induced acute lung injury.
Ren D; Sun R; Wang S
Inflamm Res; 2006 May; 55(5):207-15. PubMed ID: 16830108
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
Mark LA; Robinson AV; Schulak JA
J Surg Res; 2005 Dec; 129(2):236-41. PubMed ID: 16140334
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage.
Alayan J; Ivanovski S; Gemmell E; Ford P; Hamlet S; Farah CS
Oral Microbiol Immunol; 2006 Dec; 21(6):360-5. PubMed ID: 17064393
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporin A on the expression of inducible nitric oxide synthase in the gingiva of rats.
Gau CH; Chou TC; Chiu HC; Shen EC; Nieh S; Chiang CY; Fu E
J Periodontol; 2005 Dec; 76(12):2260-6. PubMed ID: 16332238
[TBL] [Abstract][Full Text] [Related]
17. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
18. [NO2-/NO3- levels in blood and principal organs in rats treated with lipopolysaccharide].
Sakemi K; Ohno Y; Tsuda M
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):101-6. PubMed ID: 10097517
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide protection against adriamycin-induced tubulointerstitial injury.
Oteki T; Nagase S; Shimohata H; Hirayama A; Ueda A; Yokoyama H; Yoshimura T
Free Radic Res; 2008 Feb; 42(2):154-61. PubMed ID: 18297608
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor.
Chida N; Hirasawa Y; Ohkawa T; Ishii Y; Sudo Y; Tamura K; Mutoh S
Eur J Pharmacol; 2005 Feb; 509(1):71-6. PubMed ID: 15713431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
